Canon Medical Receives FDA Clearance for Advanced Interventional Imaging Systems with AI-Enhanced Technology
Key Insights
Canon Medical Systems USA (search) received FDA 510(k) clearance for the Alphenix/Evolve Edition (search) with αEvolve Imaging (search), featuring deep learning technology for enhanced fluoroscopic imaging during percutaneous coronary interventions (search).
The company also announced FDA clearance for the Alphenix 4D CT (search) with Aquilion ONE/INSIGHT Edition (search), a hybrid angio-CT system that enables diagnosis, planning, treatment, and verification in a single room.
Both systems incorporate artificial intelligence solutions including deep learning-based noise reduction, multi-frequency processing, and AI-assisted workflow capabilities to improve procedural precision and clinical confidence.
Canon Medical Systems USA (search) has achieved two significant FDA 510(k) clearances for advanced interventional imaging systems that integrate artificial intelligence and deep learning technologies to enhance procedural precision and clinical workflows. The clearances mark a major milestone in interventional cardiology and radiology imaging capabilities.
Alphenix/Evolve Edition Brings AI to Interventional Cardiology
The Alphenix/Evolve Edition (search) with αEvolve Imaging (search) received FDA 510(k) clearance for enhanced fluoroscopic imaging during routine and complex percutaneous coronary interventions (search) (PCI). The system utilizes deep learning technology in real-time to improve imaging quality and support critical diagnostic and therapeutic decisions without disrupting procedural flow.
"Our commitment to empowering healthcare professionals with intelligent imaging tools has led to this milestone, an FDA 510 (k) clearance," said Bill Newman, Vice President Interventional Vascular, Canon Medical Systems USA (search). "αEvolve Imaging (search) brings meaningful innovation to interventional cardiology—helping teams visualize with greater clarity while maintaining procedural efficiency."
The αEvolve technology umbrella includes several AI-powered solutions. The Dynamic Device Stabilizer (DDS), trained with deep learning, automatically detects balloon markers in real-time, magnifies, and stabilizes the image on a separate screen to assist with stent visualization and assessment during complex PCI procedures. Additional features include Artificial Intelligence Denoising (AID) for reduced image noise during fluoroscopy and Multi-Frequency Processing (MFP) to maintain image detail and enhance visibility.
αEvolve Imaging (search) employs deep learning-based noise reduction and multi-frequency processing to deliver sharp, clear fluoroscopic images. The technology is currently available for 6" and 8" field of view 12x12-inch High-Definition flat panel detectors, depending on system configuration.
Extensive internal bench testing and real-world clinical image reviews demonstrated significant improvements in image contrast, sharpness, and noise levels, supporting more confident and efficient interventions. The Alphenix/Evolve Edition (search) is now commercially available in the United States.
Hybrid Angio-CT System Revolutionizes Interventional Imaging
Canon Medical also announced FDA clearance for the Alphenix 4D CT (search) with Aquilion ONE/INSIGHT Edition (search), described as the most advanced interventional imaging equipment available. The company is on schedule to make the system commercially available in summer 2026.
This next-generation Angio-CT hybrid one-suite solution combines the Alphenix Sky+ angiography system with the award-winning Aquilion ONE/INSIGHT Edition (search) CT scanner. The integrated system enables diagnosis, planning, treatment, and verification in one room, all but eliminating the need for patient transfer between departments.
"Our innovative technology meets the evolving needs of healthcare professionals, enhancing workflow and enabling our customers to prioritize clinical decisions for patients," said Hisashi Tachizaki, President and CEO, Canon Medical Systems USA (search). "We are proud that Canon Medical's Alphenix 4D CT (search) system is adopted globally to support patient care in the fields of interventional radiology, oncology, cardiology, pediatrics, neurosurgery, trauma, and other specialties."
Advanced Technical Capabilities
The Alphenix Sky+ provides the world's only high-definition flat panel detector with unique 76 μm pixel technology. The Aquilion ONE/INSIGHT Edition (search) features a 16 cm wide-area detector and includes Canon's Precise IQ Engine (PIQE) Deep Learning Reconstruction, and AI-assisted workflow experience.
This powerful combination delivers cross-sectional imaging with an ultra-fast down to 0.24 second rotation speed and wide-area detector, enabling full organ coverage in a single rotation. The setup enables optimized patient care, with fewer transfers, enhanced precision, and dose optimization for both patients and medical teams.
Global Clinical Implementation
The Centre Hospitalier Universitaire (CHU) of Montpellier (search) serves as the first global installation of the Alphenix 4D CT (search) in combination with Aquilion ONE/INSIGHT Edition (search). According to Professor Guiu, "This new system offers us new therapeutic possibilities thanks to unparalleled precision and greater procedure safety."
Canon Medical showcased both systems at major medical conferences, with the Alphenix/Evolve Edition (search) debuted at the Transcatheter Cardiovascular Therapeutics (TCT) Conference held from October 25 to 28, 2025, at the Moscone Center in San Francisco. The Alphenix 4D CT (search) system is being displayed at the annual meeting of the Radiological Society of North America (RSNA 2025) in Chicago from November 30 to December 4.